이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

유아 및 소아에서 말초정맥주사관 설치 시 통증 관리에 있어 치료 보조 로봇 파로의 효과 평가 (PARO)

2026년 11월 17일 업데이트: Fondation Lenval

영아 및 소아의 말초정맥주사관 설치 시 통증 관리에서 치료 보조 로봇 파로의 평가, 다기관 무작위 전향적 연구.

Peripheral intravenous catheterization is one of the most frequently performed procedures in pediatric emergency departments and hospital units. It is often associated with significant anxiety in both children and their parents, which may exacerbate the pain experienced during the procedure, as fear and pain are closely interrelated. Effective management of pain and anxiety is therefore essential to optimize the child's well-being in the short, medium, and long term.

The quality of pediatric analgesia relies on a multimodal approach combining pharmacological and non-pharmacological interventions. In recent years, several non-pharmacological strategies have been developed to reduce pain and anxiety. Among these, innovative technologies such as therapeutic assistance robots incorporating artificial intelligence have emerged; however, their clinical benefits remain to be established.

The present study aims to evaluate the effectiveness of PARO, a therapeutic assistance robot designed in the form of a baby seal, in the management of pain during peripheral intravenous catheterization in children. The investigators will compare the effects of PARO in combination with standard care versus standard care alone during needle-related procedures. The primary objective is to determine whether the use of this device improves pain management in children undergoing skin puncture.

This study is designed as a multicenter, randomized, open-label, superiority trial conducted across five pediatric centers. A total of 120 infants and children aged 12 months to 7 years undergoing peripheral intravenous catheterization will be enrolled. Pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) observational scale, which is validated for this age group.

Secondary objectives include the assessment and comparison of procedural distress between groups using the PRIC (Procedural Restraint Intensity in Children) score, evaluation of heart rate variability, number of catheterization attempts, parental anxiety measured by the STAI (State-Trait Anxiety Inventory), and satisfaction levels among both parents and healthcare staff.

연구 개요

연구 유형

중재적

등록 (추정된)

120

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

      • Brest, 프랑스
        • 아직 모집하지 않음
        • Chu Morvan
        • 연락하다:
      • Grasse, 프랑스
        • 아직 모집하지 않음
        • Centre hospitaliers de Grasse
        • 연락하다:
      • Nice, 프랑스, 06000
        • 모병
        • Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval
        • 연락하다:
        • 수석 연구원:
          • Barabra LE GALLO, MD
      • Nice, 프랑스
        • 모병
        • CHU de NICE
        • 연락하다:
      • Toulouse, 프랑스, 31059
        • 아직 모집하지 않음
        • Centre Hospitalier Universitaire Toulouse
        • 연락하다:
        • 수석 연구원:
          • Camille Brehin, Pr

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

1년 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  1. Age between 12 months and 7 years.
  2. Requirement for peripheral intravenous catheterization (PIC).
  3. Written informed consent obtained from at least one parent or legal guardian.
  4. Affiliation with the national health insurance system (social security).

Exclusion Criteria:

  1. Requirement for contact isolation, including colonization or infection with multidrug-resistant organisms (MDROs).
  2. Visual or hearing impairment.
  3. Known psychiatric disorder.
  4. Inability to understand French.
  5. Life-threatening emergency requiring immediate intervention.
  6. Need for strong analgesic medication (e.g., morphine, ketamine, or intranasal analgesics).

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Control group : standard multimodal stratgey

The child will be admitted to the emergency department.

If topical anesthesia (EMLA cream) is used for pain prevention, it will be applied to the skin prior to the procedure.

If analgesia with MEOPA (equimolar mixture of oxygen and nitrous oxide) is indicated, the child will inhale the gas via a mask during the procedure.

Non-pharmacological interventions, such as music therapy and/or watching cartoons, may also be used as part of standard care.

The procedure will begin with skin disinfection and identification of a suitable vein.

For the purposes of the study, the start of the procedure is defined as the moment the needle first penetrates the skin.

The procedure is considered complete once the needle is withdrawn and a dressing is applied.

Pharmacological interventions:

EMONO (Equimolar Mixture of Oxygen and Nitrous Oxide) EMLA cream (Eutectic Mixture of Local Anesthetics)

Non-pharmacological interventions:

Music therapy Audiovisual distraction (e.g., watching cartoons)

실험적: Experimental group: Standard multimodal pain management strategy supplemented by the PARO therapeuti

The child will be admitted to the emergency department.

If topical anesthesia (EMLA cream) is used to reduce pain, it will be applied to the skin 30 to 60 minutes prior to the procedure.

To facilitate familiarization with the PARO therapeutic robot, the device will be placed on or next to the child's lap approximately 15 minutes before the start of the procedure.

If analgesia with MEOPA (equimolar mixture of oxygen and nitrous oxide) is indicated, a face mask delivering the gas will be applied to the child.

The procedure will begin with skin disinfection and identification of a suitable vein.

For study purposes, the start of the procedure is defined as the moment the needle first penetrates the skin.

The procedure will be considered complete once the needle is withdrawn and a dressing is applied.

The child will be admitted to the emergency department.

If topical anesthesia (EMLA cream) is used for pain prevention, it will be applied to the skin 30 to 60 minutes prior to the procedure.

To facilitate familiarization with the PARO therapeutic robot, the device will be placed on or next to the child's lap approximately 15 minutes before the start of the procedure.

If analgesia with MEOPA (equimolar mixture of oxygen and nitrous oxide) is indicated, a face mask delivering the gas will be applied to the child during the procedure.

The procedure will begin with skin disinfection and identification of a suitable vein.

For study purposes, the start of the procedure is defined as the moment the needle first penetrates the skin.

The procedure will be considered complete once the needle is withdrawn and a dressing is applied.

다른 이름들:
  • PARO group

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
FLACC(Face-Legs-Activity-Cry-Consolability) -assessed procedural pain during peripheral intravenous catheterization
기간: periprocedural

The effectiveness of PARO in reducing procedural pain will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) observational scale. The FLACC is a validated hetero-assessment tool for evaluating pain in children aged 12 months to 7 years, particularly in the context of acute postoperative pain and brief painful medical procedures.

This scale evaluates five behavioral domains: facial expression, leg movement, activity, crying, and consolability. Each item is scored from 0 to 2, resulting in a total score ranging from 0 to 10. A score of 0 indicates a relaxed and comfortable child, while scores of 7 to 10 indicate severe pain or significant distress. A score of ≥3 is commonly considered indicative of clinically relevant pain requiring analgesic intervention.

periprocedural

2차 결과 측정

결과 측정
측정값 설명
기간
Procedural distress assessed using the PRIC (Procedural Restraint Intensity in Children) scale during peripheral intravenous catheterization
기간: skin disinfection AND Skin penetration

Children's distress will be evaluated using the PRIC scale (Procedural Restraint Intensity in Children), which measures the intensity of restraint required during pediatric procedures as an indirect indicator of procedural distress. The scale is stratified into five levels, assessing both the degree of physical restraint applied and the child's behavioral response. A score ≥3 is considered clinically significant and should prompt reassessment of pain and/or anxiolytic management. The PRIC scale has been preliminarily validated in a cohort of 20 children aged 2 months to 13 years, showing acceptable metrological properties; however, further studies are ongoing to confirm its validity in real-life clinical settings, as no gold standard currently exists. Procedural distress will be assessed at two time points: during skin disinfection with identification of the puncture site, and at skin penetration. Results will be compared between groups

skin disinfection AND Skin penetration
Heart rate variability as an indicator of procedural pain during peripheral intravenous catheterization
기간: periprocedural

Heart rate variability may serve as an indirect indicator of pain intensity, reflecting autonomic (sympathetic and parasympathetic) responses to nociceptive stimulation. Heart rate is a recognized physiological marker of pain in infants and children and may increase by approximately 10 to 25 beats per minute during painful procedures.

In this study, heart rate will be used to assess the effect of PARO on procedural pain. It will be continuously monitored using standard clinical monitoring equipment. Measurements will be recorded at two time points: 15 minutes before the procedure during PARO introduction (if applicable), and at the time of venipuncture. The primary analysis will focus on the change (delta) in heart rate between baseline (15 minutes before the procedure) and venipuncture. Comparisons will be made between study groups.

periprocedural
Number of attempts required for successful peripheral venous access
기간: During the procedure (up to 3 attempts)

The effectiveness of the procedure will also be assessed by the number of attempts required to establish peripheral venous access. An attempt is defined as each skin puncture attempt. For ethical reasons, a maximum of three attempts will be permitted; beyond this threshold, the procedure will be considered a failure and alternative management in the operating room will be proposed.

During the procedure (up to 3 attempts)
Assessment of parental satisfaction
기간: 15 minutes after the end of the procedure

Parental satisfaction will be evaluated using a structured questionnaire administered to parents following the procedure. The instrument includes four items rated on a Likert-type response scale.

15 minutes after the end of the procedure
Parental anxiety assessed using the State-Trait Anxiety Inventory (STAI)
기간: at the end of the procedure

Parental anxiety will be assessed using the State-Trait Anxiety Inventory (STAI). The STAI is a self-administered questionnaire consisting of 40 items divided into two subscales: the State Anxiety subscale (STAI Form Y-1), which assesses current anxiety levels, and the Trait Anxiety subscale (STAI Form Y-2), which assesses general predisposition to anxiety.

Each item is rated on a 4-point Likert scale, with scores ranging from 1 (low anxiety) to 4 (high anxiety).

at the end of the procedure
Failure of peripheral venous access after three attempts
기간: periprocedural

Failure of peripheral intravenous catheterization is defined as the inability to establish venous access after a maximum of three attempts, as previously defined, necessitating management by the anesthesia team.

periprocedural
Assessment of paramedical staff satisfaction
기간: 15 minutes after the end of the procedure.

Satisfaction of the paramedical team will be assessed using a dedicated questionnaire administered to all nursing staff involved in the study at the end of the trial. The questionnaire will be completed once by each participant and consists of four items rated on a Likert-type scale.

In addition, one or more debriefing meetings will be organized with the care team at study completion to gather qualitative feedback regarding their experience and perceptions of the intervention

15 minutes after the end of the procedure.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Barbara LE GALLO, MD, Hôpitaux pédiatrique Nice CHU Lenval

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 3월 3일

기본 완료 (추정된)

2027년 3월 30일

연구 완료 (추정된)

2027년 3월 30일

연구 등록 날짜

최초 제출

2025년 11월 27일

QC 기준을 충족하는 최초 제출

2025년 12월 9일

처음 게시됨 (실제)

2025년 12월 23일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 20일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 17일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

키워드

기타 연구 ID 번호

  • 24-HPNCL-05 PARO
  • 2025-A00197-42 (기타 식별자: ANSM)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다